INS and type 2 diabetes mellitus: Furthermore, the type of therapy used in type 2 diabetes also influenced the differences in patient survival: using only metformin (survival: 26.13%, death: 13.08%) versus insulin and other antidiabetic drugs (survival: 9.61%, death: 16.82%) had different results, which, of course, stemmed from the stage of advancement of T2DM.